{"id":119028,"date":"2026-06-17T12:01:22","date_gmt":"2026-06-17T06:31:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=119028"},"modified":"2026-06-17T12:01:24","modified_gmt":"2026-06-17T06:31:24","slug":"epigral-stock-prediction-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/","title":{"rendered":"Epigral Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Epigral (NSE:EPIGRAL) CMP: Rs 1,148.8 (2026). 52W High: Rs 2,114. 52W Low: Rs 806. MCap: Rs 4,941 Cr. P\/E: 15.2. Sector: Specialty Chemicals and Agrochemicals. JM Financial: Neutral Rs 1350. Kotak &#8230;<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/user\/stocks\/epigral\/epigral-ltd-share-price-today\">Epigral<\/a> stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Epigral share price prediction as one data point and not as a guarantee of future performance.<\/p>\n<p>This article reviews every dimension of the Epigral stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=epigral-stk-pred\" target=\"_blank\" rel=\"noopener\">Click Here &#8211; Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_Analysts_Predict_for_Epigral_Stock_in_2026\" title=\"What Analysts Predict for Epigral Stock in 2026\">What Analysts Predict for Epigral Stock in 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Epigral_Company_Overview\" title=\"Epigral Company Overview\">Epigral Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Epigral_Stock_Prediction_by_Time_Horizon\" title=\"Epigral Stock Prediction by Time Horizon\">Epigral Stock Prediction by Time Horizon<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Short-Term_Epigral_Stock_Prediction\" title=\"Short-Term Epigral Stock Prediction\">Short-Term Epigral Stock Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#12-Month_Epigral_Stock_Prediction\" title=\"12-Month Epigral Stock Prediction\">12-Month Epigral Stock Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Long-Term_Epigral_Stock_Prediction\" title=\"Long-Term Epigral Stock Prediction\">Long-Term Epigral Stock Prediction<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Epigral_Stock_Forecast_Key_Factors\" title=\"Epigral Stock Forecast: Key Factors\">Epigral Stock Forecast: Key Factors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Export_Revenue_Recovery\" title=\"Export Revenue Recovery\">Export Revenue Recovery<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Capacity_Utilisation_and_Operating_Leverage\" title=\"Capacity Utilisation and Operating Leverage\">Capacity Utilisation and Operating Leverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Product_Mix_and_Value_Addition\" title=\"Product Mix and Value Addition\">Product Mix and Value Addition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#EBITDA_Margin_Trajectory\" title=\"EBITDA Margin Trajectory\">EBITDA Margin Trajectory<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Epigral_Stock_Prediction_Bull_and_Bear_Scenarios\" title=\"Epigral Stock Prediction: Bull and Bear Scenarios\">Epigral Stock Prediction: Bull and Bear Scenarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#How_Analysts_Are_Reading_the_Epigral_Stock_Story\" title=\"How Analysts Are Reading the Epigral Stock Story\">How Analysts Are Reading the Epigral Stock Story<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Key_Risks_to_the_Epigral_Stock_Prediction\" title=\"Key Risks to the Epigral Stock Prediction\">Key Risks to the Epigral Stock Prediction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#China_Competition\" title=\"China Competition\">China Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Raw_Material_Cost_Volatility\" title=\"Raw Material Cost Volatility\">Raw Material Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Export_Demand_Weakness\" title=\"Export Demand Weakness\">Export Demand Weakness<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Regulatory_and_Environmental_Risk\" title=\"Regulatory and Environmental Risk\">Regulatory and Environmental Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#How_to_Monitor_the_Epigral_Stock_Forecast\" title=\"How to Monitor the Epigral Stock Forecast\">How to Monitor the Epigral Stock Forecast<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Frequently_Asked_Questions_on_Epigral_Stock_Prediction_2026\" title=\"Frequently Asked Questions on Epigral Stock Prediction 2026\">Frequently Asked Questions on Epigral Stock Prediction 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_is_the_Epigral_stock_prediction_for_2026\" title=\"What is the Epigral stock prediction for 2026?\">What is the Epigral stock prediction for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Is_the_Epigral_stock_prediction_bullish_or_bearish\" title=\"Is the Epigral stock prediction bullish or bearish?\">Is the Epigral stock prediction bullish or bearish?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_is_the_Epigral_share_price_prediction_based_on_fundamentals\" title=\"What is the Epigral share price prediction based on fundamentals?\">What is the Epigral share price prediction based on fundamentals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_is_the_long-term_Epigral_stock_prediction\" title=\"What is the long-term Epigral stock prediction?\">What is the long-term Epigral stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_are_the_key_risks_to_the_Epigral_stock_prediction\" title=\"What are the key risks to the Epigral stock prediction?\">What are the key risks to the Epigral stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#What_does_the_Epigral_stock_forecast_say_for_2026\" title=\"What does the Epigral stock forecast say for 2026?\">What does the Epigral stock forecast say for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/epigral-stock-prediction-2026\/#Where_can_I_track_the_latest_Epigral_stock_prediction\" title=\"Where can I track the latest Epigral stock prediction?\">Where can I track the latest Epigral stock prediction?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Analysts_Predict_for_Epigral_Stock_in_2026\"><\/span><strong>What Analysts Predict for Epigral Stock in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analyst consensus on the Epigral stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Epigral Stock Prediction (Rs)<\/th>\n<th>Updated<\/th>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Rs 1350<\/td>\n<td>2026<\/td>\n<\/tr>\n<tr>\n<td>Kotak Securities<\/td>\n<td>Neutral<\/td>\n<td>Rs 1260<\/td>\n<td>2026<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus<\/td>\n<td>&#8212;<\/td>\n<td>Rs 1305<\/td>\n<td>2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The analyst target range for Epigral reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Epigral stock forecast from the current price of Rs 1,148.8 may or may not be realised by end of 2026.<\/p>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Epigral_Company_Overview\"><\/span><strong>Epigral Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Epigral is a specialty chemicals or agrochemical company serving domestic and global markets. The Epigral stock prediction for 2026 reflects export recovery potential and margin expansion from operating leverage.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>EPIGRAL<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Specialty Chemicals and Agrochemicals<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 1,148.8 (2026)<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 2,114<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 806<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 4,941 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>15.2<\/td>\n<\/tr>\n<tr>\n<td>Epigral Stock Prediction Consensus (12M)<\/td>\n<td>Rs 1305<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Epigral_Stock_Prediction_by_Time_Horizon\"><\/span><strong>Epigral Stock Prediction by Time Horizon<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analysts split the Epigral share price prediction across time frames as near-term drivers differ materially from the long-term view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Short-Term_Epigral_Stock_Prediction\"><\/span><strong>Short-Term Epigral Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The near-term Epigral stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,148.8 are being watched closely. A short-term Epigral share price prediction carries the most uncertainty of any time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Epigral_Stock_Prediction\"><\/span><strong>12-Month Epigral Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>JM Financial targets Rs 1350 (Neutral) and Kotak Securities targets Rs 1260 (Neutral). Most desks refresh their Epigral stock forecast within two to four weeks of each quarterly earnings print. The Epigral share price prediction should be verified against the most recent analyst reports.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long-Term_Epigral_Stock_Prediction\"><\/span><strong>Long-Term Epigral Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The long-term outlook for Epigral is built on assumptions about demand recovery, margin expansion and revenue diversification in the Specialty Chemicals and Agrochemicals sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Epigral_Stock_Forecast_Key_Factors\"><\/span><strong>Epigral Stock Forecast: Key Factors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The following four factors appear consistently in analyst research on Epigral and are the primary inputs into the bull and bear case scenarios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Export_Revenue_Recovery\"><\/span><strong>Export Revenue Recovery<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A recovery in global chemical demand is the primary catalyst in the Epigral stock forecast. Analysts who set a higher Epigral stock prediction point to export order recovery as their main justification for the Epigral share price prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Capacity_Utilisation_and_Operating_Leverage\"><\/span><strong>Capacity Utilisation and Operating Leverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising capacity utilisation from recent capital investment drives operating leverage and margin expansion. Analysts revise the Epigral share price prediction upward when utilisation improves.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Product_Mix_and_Value_Addition\"><\/span><strong>Product Mix and Value Addition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A shift toward higher-value specialty products improves realization. Analysts track the specialty-to-commodity revenue ratio in their Epigral share price prediction models.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"EBITDA_Margin_Trajectory\"><\/span><strong>EBITDA Margin Trajectory<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained EBITDA margin is typically the basis for the bullish Epigral stock prediction. Margin recovery is the single most important variable in the Epigral stock forecast from most research desks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Epigral_Stock_Prediction_Bull_and_Bear_Scenarios\"><\/span><strong>Epigral Stock Prediction: Bull and Bear Scenarios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Epigral Stock Prediction<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1350<\/td>\n<td>Strong execution, margin improvement, favourable macro and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 1305<\/td>\n<td>Steady performance, gradual recovery, margins hold, growth on track<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 806<\/td>\n<td>Demand deterioration, margin pressure, sector de-rating and macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The bull case Epigral stock forecast of Rs 1350 assumes most positive variables converge. The base case of Rs 1305 is the analyst consensus and may or may not be achieved.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Analysts_Are_Reading_the_Epigral_Stock_Story\"><\/span><strong>How Analysts Are Reading the Epigral Stock Story<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analyst reviews of the Epigral share price prediction highlight the company&#8217;s core strengths in Specialty Chemicals and Agrochemicals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Epigral is built on real business strengths set against real risks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Epigral_Stock_Prediction\"><\/span><strong>Key Risks to the Epigral Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"China_Competition\"><\/span><strong>China Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Chinese producers compete aggressively on price. Dumping risk and China&#8217;s overcapacity are structural headwinds to the Epigral stock prediction reflected in the cautious Epigral share price prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Raw_Material_Cost_Volatility\"><\/span><strong>Raw Material Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Petrochemical feedstocks see frequent price swings. Sustained input cost increases compress margins and force downward revisions to the Epigral stock forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Export_Demand_Weakness\"><\/span><strong>Export Demand Weakness<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global industrial demand weakness or inventory destocking by key export customers directly affects volumes and the Epigral share price prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Regulatory_and_Environmental_Risk\"><\/span><strong>Regulatory and Environmental Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Increasing environmental and safety regulations affect compliance costs and are recurring risks to the Epigral share price prediction.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Monitor_the_Epigral_Stock_Forecast\"><\/span><strong>How to Monitor the Epigral Stock Forecast<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Track the Epigral share price prediction consensus quarterly. After every earnings release, most brokerages revise their Epigral stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Epigral is improving or deteriorating.<\/p>\n<p>Compare the current price of Rs 1,148.8 with the analyst target range of Rs 1350 to Rs 1260. A wide target band reflects genuine uncertainty on Epigral, so position size should reflect that range rather than the midpoint alone.<\/p>\n<p>Review the Epigral share price prediction every quarter against key business metrics for the Specialty Chemicals and Agrochemicals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\" target=\"_blank\" rel=\"noopener\">Check Live Epigral Fundamentals on the Univest Screener<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Epigral stock prediction for 2026 reflects the analyst community&#8217;s assessment of Epigral&#8217;s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 1350 while Kotak Securities has a Neutral rating with a target of Rs 1260, giving an analyst consensus of Rs 1305.<\/p>\n<p>The Epigral stock forecast is set against near-term risks that make the Epigral share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Epigral share price target changes over time is more valuable than relying on any single estimate.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stock-advisor-broker\/id1559167021\" target=\"_blank\" rel=\"noopener nofollow\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.app\" target=\"_blank\" rel=\"noopener nofollow\">Univest Android App<\/a> to track live analyst targets, price movements and research updates for Epigral in real time.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (<a style=\"color: #ffcccc;\" href=\"https:\/\/www.nseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">nseindia.com<\/a>) and BSE (<a style=\"color: #ffcccc;\" href=\"https:\/\/www.bseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">bseindia.com<\/a>) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Epigral_Stock_Prediction_2026\"><\/span><strong>Frequently Asked Questions on Epigral Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Epigral_stock_prediction_for_2026\"><\/span><strong>What is the Epigral stock prediction for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Epigral stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 1305. All estimates may or may not be achieved.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Epigral_stock_prediction_bullish_or_bearish\"><\/span><strong>Is the Epigral stock prediction bullish or bearish?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> JM Financial has a Neutral rating with target Rs 1350. Kotak Securities has a Neutral rating with target Rs 1260. The Epigral stock forecast reflects genuine analyst diversity of opinion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Epigral_share_price_prediction_based_on_fundamentals\"><\/span><strong>What is the Epigral share price prediction based on fundamentals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Epigral share price prediction rests on the export order recovery, margin trajectory, China competition dynamics and capacity utilisation. Analysts tracking Epigral closely cite these as the primary drivers of the 2026 outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_long-term_Epigral_stock_prediction\"><\/span><strong>What is the long-term Epigral stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term outlook assumes Epigral sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1305 is the nearest reliable anchor point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Epigral_stock_prediction\"><\/span><strong>What are the key risks to the Epigral stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Epigral should be read alongside its risk assumptions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Epigral_stock_forecast_say_for_2026\"><\/span><strong>What does the Epigral stock forecast say for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> JM Financial: Neutral target Rs 1350. Kotak Securities: Neutral target Rs 1260. These Epigral share price prediction estimates may or may not prove accurate.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_the_latest_Epigral_stock_prediction\"><\/span><strong>Where can I track the latest Epigral stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Track the latest analyst targets and price movements for Epigral on the NSE and BSE websites and on the Univest app and screener for live data.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Epigral stock prediction for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Epigral stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 1305. All estimates may or may not be achieved.\"}},{\"@type\":\"Question\",\"name\":\"Is the Epigral stock prediction bullish or bearish?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JM Financial has a Neutral rating with target Rs 1350. Kotak Securities has a Neutral rating with target Rs 1260. The Epigral stock forecast reflects genuine analyst diversity of opinion.\"}},{\"@type\":\"Question\",\"name\":\"What is the Epigral share price prediction based on fundamentals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Epigral share price prediction rests on the export order recovery, margin trajectory, China competition dynamics and capacity utilisation. Analysts tracking Epigral closely cite these as the primary drivers of the 2026 outlook.\"}},{\"@type\":\"Question\",\"name\":\"What is the long-term Epigral stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The long-term outlook assumes Epigral sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1305 is the nearest reliable anchor point.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks to the Epigral stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Epigral should be read alongside its risk assumptions.\"}},{\"@type\":\"Question\",\"name\":\"What does the Epigral stock forecast say for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JM Financial: Neutral target Rs 1350. Kotak Securities: Neutral target Rs 1260. These Epigral share price prediction estimates may or may not prove accurate.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track the latest Epigral stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Track the latest analyst targets and price movements for Epigral on the NSE and BSE websites and on the Univest app and screener for live data.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Epigral stock prediction 2026 from leading analysts. JM Financial: Neutral Rs 1350. Full Epigral stock forecast for Specialty Chemicals and Agrochemicals sec&#8230;<\/p>\n","protected":false},"author":35,"featured_media":120572,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-119028","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781677894:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["71"],"rank_math_focus_keyword":["Epigral Stock Prediction 2026"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Epigral Stock Prediction 2026: Analyst Forecast and Analysis"],"rank_math_description":["Epigral stock prediction 2026 from leading analysts. Full Epigral stock forecast, bull bear scenarios and Epigral share price prediction for 2026."],"_wp_old_date":["2026-06-16"],"_thumbnail_id":["120572"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["18615"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Epigral-Stock-Prediction-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/119028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=119028"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/119028\/revisions"}],"predecessor-version":[{"id":120573,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/119028\/revisions\/120573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/120572"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=119028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=119028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=119028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}